AquaBounty Sheds Assets, Exits Salmon Farming Amidst Mounting Losses

Ticker: AQB · Form: 10-K · Filed: Mar 31, 2026 · CIK: 0001603978

Aquabounty Technologies Inc 10-K Filing Summary
FieldDetail
CompanyAquabounty Technologies Inc (AQB)
Form Type10-K
Filed DateMar 31, 2026
Risk Levelhigh
Pages15
Reading Time18 min
Key Dollar Amounts$0.001, $22.5 million, $26.3 million, $18.2 million, $57.3 million
Sentimentbearish

Sentiment: bearish

Topics: Aquaculture, Asset Divestiture, Impairment Charges, Going Concern, Strategic Alternatives, Genetically Engineered Salmon, Land-Based Farming

TL;DR

**AQB is liquidating its core assets and intellectual property, signaling a complete capitulation on its land-based salmon farming strategy.**

AI Summary

AquaBounty Technologies, Inc. (AQB) reported a strategic pivot in its 2025 fiscal year, moving away from its large-scale recirculating aquaculture system (RAS) farm construction. The company paused its 10,000 metric ton Ohio Farm Project in June 2023 due to escalating costs and financing challenges. This led to a series of asset divestitures, including the sale of its Indiana Farm in July 2024, recurring sales of Ohio Equipment Assets throughout 2024 and 2025, and the sale of its Canadian subsidiary, including broodstock farms and Corporate IP, in March 2025. These actions resulted in significant impairment charges: $22.5 million for the Indiana Farm, $26.3 million for Ohio Equipment Assets in Q2 2024, an additional $18.2 million for Ohio Equipment Assets and $57.3 million for the Ohio Farm Site at year-end 2024, and $5.4 million for Canadian Farms and $0.2 million for Corporate IP in March 2025. A further impairment charge of $14.4 million was recorded against the Ohio Farm Project in 2025, which is now classified as an asset held for sale. The company's primary remaining asset is the Ohio Farm Project, for which a non-binding Letter of Interest has been received, indicating a potential full divestiture.

Why It Matters

AquaBounty's dramatic shift from an aquaculture growth strategy to asset divestiture signals a significant failure in its commercialization plan, impacting investors who backed its land-based salmon farming vision. The substantial impairment charges totaling $14.4 million in 2025 and $129.8 million in 2024 reflect a severe erosion of asset value, raising serious questions about the viability of large-scale RAS projects in the current economic climate. This retreat could deter investment in similar capital-intensive aquaculture ventures, while employees and customers of its former farms face uncertainty. The sale of its proprietary GE Atlantic salmon IP also removes a key competitive differentiator, leaving the company's future highly speculative.

Risk Assessment

Risk Level: high — AquaBounty explicitly states a 'history of net losses and the likelihood of future net losses' and 'substantial doubt about our ability to continue as a going concern.' The company recorded massive impairment charges of $129.8 million in 2024 and $14.4 million in 2025, indicating severe asset devaluation and operational distress. The ongoing sale of its primary remaining asset, the Ohio Farm Project, underscores its precarious financial position and lack of a clear operating business.

Analyst Insight

Investors should view AQB as a distressed asset play, not an operating company. Given the explicit 'going concern' doubt and ongoing liquidation, current shareholders should consider exiting their positions, while potential investors should avoid until a clear, viable business model emerges from the current divestiture process.

Key Numbers

Key Players & Entities

FAQ

What is AquaBounty Technologies' current business strategy after the 2025 fiscal year?

AquaBounty Technologies has shifted from a growth strategy focused on large-scale recirculating aquaculture system (RAS) farms to one of asset divestiture. The company has sold its Indiana Farm, Canadian Farms, and its intellectual property for GE Atlantic salmon. Its primary remaining asset is the Ohio Farm Project, which is also being considered for sale following a non-binding Letter of Interest.

How much in impairment charges did AquaBounty record in 2024 and 2025?

AquaBounty recorded total impairment charges of $129.8 million in 2024, including $22.5 million for the Indiana Farm, $26.3 million for Ohio Equipment Assets, $18.2 million for additional Ohio Equipment Assets, and $57.3 million for the Ohio Farm Site. In 2025, the company recorded an additional $14.4 million impairment charge against the Ohio Farm Project, along with $5.4 million for Canadian Farms and $0.2 million for Corporate IP.

Why did AquaBounty pause the construction of its Ohio Farm Project?

AquaBounty paused the construction of its 10,000 metric ton Ohio Farm Project in June 2023 because the estimated cost to complete the farm substantially increased due to inflation and other factors. These rising costs also impaired the company's ability to secure municipal bond financing, which was a critical part of its funding strategy.

What is the status of AquaBounty's genetically engineered Atlantic salmon intellectual property?

AquaBounty sold the intellectual property for its genetically engineered Atlantic salmon, along with trademarks and patents (Corporate IP), as part of the transaction to sell its Canadian subsidiary in March 2025. This means the company no longer owns the core technology that defined its previous business model.

Does AquaBounty Technologies currently operate any salmon farms?

No, AquaBounty Technologies does not currently operate any salmon farms. The company has sold its Indiana Farm and its Canadian Farms. Its primary remaining asset, the Ohio Farm Project, consists of land and construction in process, and is classified as an asset held for sale.

What are the key risks highlighted in AquaBounty's 10-K filing?

Key risks include a history of net losses and expected future losses, substantial doubt about the company's ability to continue as a going concern, the need to raise additional funds, potential delays or denials of approvals for the Ohio Farm Project, and the volatility in the price of its common stock. The company also faces risks related to maintaining its Nasdaq listing and potential further write-downs of assets.

What was the market value of AquaBounty's common stock held by non-affiliates at June 30, 2025?

At June 30, 2025, the aggregate market value of the 3,838,910 shares of common stock held by non-affiliates of AquaBounty Technologies was approximately $2.8 million.

What is the significance of AquaBounty being a 'smaller reporting company' and 'non-accelerated filer'?

AquaBounty's status as a 'smaller reporting company' and a 'non-accelerated filer' means it is subject to scaled disclosure requirements. The company notes that it cannot be certain if these applicable scaled disclosure requirements will make its shares of common stock less attractive to investors.

What is AquaBounty's stance on paying cash dividends in the foreseeable future?

AquaBounty Technologies explicitly states that it does not anticipate paying cash dividends in the foreseeable future. This is consistent with a company facing significant financial challenges and a history of net losses.

How has the aquaculture industry been performing according to the FAO data cited by AquaBounty?

According to the FAO, the aquaculture industry was a $296 billion industry in 2022, with salmon farming accounting for $22 billion. Global fish consumption has been growing faster than all other animal protein foods, and aquaculture fish production grew from 14 million metric tons to 94 million metric tons in 2022, now accounting for 51% of global fish production.

Risk Factors

Industry Context

The aquaculture industry is characterized by increasing global demand for seafood, driven by population growth and a desire for sustainable protein sources. However, it faces challenges related to environmental impact, disease management, and the high capital costs associated with advanced farming technologies like Recirculating Aquaculture Systems (RAS). Competitors range from traditional open-net pen farms to other land-based RAS operators, all vying for market share and investment.

Regulatory Implications

AquaBounty's business, particularly its genetically engineered salmon, has faced regulatory scrutiny in the past. While the company has navigated these hurdles, ongoing compliance with evolving regulations regarding genetically modified organisms (GMOs) and food safety remains a critical factor. Changes in regulatory landscapes or public acceptance could impact market access and product viability.

What Investors Should Do

  1. Monitor the outcome of the potential sale of the Ohio Farm Project.
  2. Assess the company's ability to address its 'going concern' status.
  3. Evaluate the impact of past asset impairments on future profitability.
  4. Scrutinize any new strategic initiatives or financing plans.

Key Dates

Glossary

Recirculating Aquaculture System (RAS)
A method of farming fish in contained systems that recirculate and treat water, allowing for precise control over environmental conditions. (This was AquaBounty's primary technology for its large-scale farm projects, the development of which has been significantly curtailed.)
Impairment Charge
A reduction in the carrying value of an asset on a company's balance sheet when its fair value is less than its book value. (AquaBounty has recorded substantial impairment charges, indicating significant devaluation of its assets, particularly related to the paused Ohio Farm Project and divested operations.)
Discontinued Operation
A component of a business that has been disposed of or is classified as held for sale, and whose operations and cash flows can be clearly distinguished from the rest of the company. (The Ohio Farm Project, Indiana Farm, and Canadian Farms have been classified as discontinued operations, signaling a strategic shift and potential exit from these business segments.)
Asset Held for Sale
An asset that management has committed to sell and is actively marketed, meeting specific accounting criteria for classification. (The Ohio Farm Project is classified as an asset held for sale, indicating management's intent to divest this remaining significant asset.)
Going Concern
The assumption that a business will continue to operate for the foreseeable future without the threat of liquidation. (The company's history of net losses and ongoing financial challenges raise substantial doubt about its ability to continue as a going concern.)

Year-Over-Year Comparison

The company's financial narrative has drastically shifted from growth-oriented expansion to asset divestiture and restructuring. While specific revenue and net income figures for the current fiscal year are not detailed in the provided excerpts, the significant impairment charges ($129.8 million in 2024 and additional charges in 2025) indicate a severe decline in asset values compared to previous periods. The focus has moved from building large-scale farms to managing the wind-down of past projects and exploring the sale of remaining assets, suggesting a contraction rather than growth in operational scale and asset base.

Filing Stats: 4,557 words · 18 min read · ~15 pages · Grade level 15.1 · Accepted 2026-03-31 08:05:33

Key Financial Figures

Filing Documents

Business

Business 1 Item 1A.

Risk Factors

Risk Factors 4 Item 1B. Unresolved Staff Comments 10 Item 1C. Cybersecurity 10 Item 2.

Properties

Properties 11 Item 3.

Legal Proceedings

Legal Proceedings 11 Item 4. Mine Safety Disclosures 11 PART II Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 11 Item 6. Reserved 12 Item 7.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 12 Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 17 Item 8.

Financial Statements and Supplementary Data

Financial Statements and Supplementary Data 18 Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure 18 Item 9A.

Controls and Procedures

Controls and Procedures 18 Item 9B. Other Information 19 Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 19 PART III Item 10. Directors, Executive Officers and Corporate Governance 19 Item 11.

Executive Compensation

Executive Compensation 19 Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 19 Item 13. Certain Relationships and Related Transactions, and Director Independence 19 Item 14. Principal Accountant Fees and Services 19 PART IV Item 15. Exhibit and Financial Statement Schedules 20 Item 16. Form 10-K Summary 23

SIGNATURES

SIGNATURES 23 Table of Contents CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This Annual Report on Form 10K of AquaBounty Technologies, Inc. ("AquaBounty," the "Company," "we," "us" or "our"), particularly the sections titled "Summary," "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Business," contains forward-looking statements. All statements other than present and historical facts and conditions contained in this Annual Report on Form 10K, including statements regarding our future results of operations and financial position, business strategy, plans, and our objectives for future operations, are forward-looking statements. When used in this Annual Report on Form 10K, the words "anticipate," "believe," "can," "could," "estimate," "expect," "intend," "is designed to," "may," "might," "plan," "potential," "predict," "objective," "should," or the negative of these and similar expressions identify forward-looking statements. These forward-looking statements include statements that are not historical facts, including statements regarding management's expectations for future financial and operational performance and operating expenditures, expected growth, and business outlook; the nature of and progress toward our commercialization plan; the future introduction of our products to consumers; the countries in which we may obtain regulatory approval and the progress toward such approvals; the volume of eggs or fish we may be able to produce; the timeline for our production of saleable fish; the expected advantages of land-based systems over sea-cage production; the validity and impact of legal actions; the completion of renovations at our farms; and the establishment of a larger-scale grow-out facility. We have based these forward-looking statements on our current expectations, assumptions, estimates, and projections. While we believe these expectations, assumptions, estimates, and projection

Business

Item 1. Business Overview Company Update AquaBounty has historically pursued a growth strategy that included the construction of large-scale recirculating aquaculture system ("RAS") farms for producing our genetically engineered Atlantic salmon (the "GE Atlantic salmon"). We had commenced construction of a 10,000 metric ton farm in Pioneer, Ohio (the "Ohio Farm Project"), but paused the construction in June 2023, as the cost estimate to complete the farm continued to substantially increase due to inflation and other factors. Further, these cost increases impaired our ability to pursue municipal bond financing, which was a necessary component of our funding strategy. We subsequently engaged an investment bank to pursue a range of funding and strategic alternatives, and to assist management in the prioritization of our core assets. These efforts resulted in the sale of our grow-out farm in Indiana ("Indiana Farm") in July 2024, recurring sales throughout 2024 and 2025 of selected equipment originally intended for the Ohio Farm Project ("Ohio Equipment Assets"), and the sale of our Canadian subsidiary, including the broodstock farms owned by the Canadian subsidiary in Prince Edward Island, Canada ("Canadian Farms"), and our intellectual property for the GE Atlantic salmon, along with trademarks and patents ("Corporate IP") in March 2025. After completion of these transactions, our primary remaining asset is our investment in the Ohio Farm Project, consisting of the remaining Ohio Equipment Assets and the land and construction in process (the "Ohio Farm Site"). We continue to work with an investment bank to identify the optimal path forward for realizing the potential of this asset, including its possible sale. Discontinued Operations As noted above, we sold our Indiana Farm in July 2024, our Canadian Farms in March 2025, and have been selling Ohio Equipment Assets to generate liquidity. In conjunction with the work that our investment bank has done to help us

Risk Factors

Item 1A. Risk Factors The following are certain risk factors that could affect our business, financial condition, and results of operations. You should carefully consider the risks described below, together with the other information contained in this Annual Report on Form 10K, including our consolidated financial statements and the related notes. We cannot assure you that any of the events discussed in the risk factors below will not occur. These risks could have a material and adverse impact on our business, results of operations, financial condition, or prospects. If that were to happen, the trading price of our common stock could decline, and you could lose all or part of your investment. This Annual Report on Form 10K also contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including the risks faced by us described below and elsewhere in this Annual Report on Form 10K. See "Cautionary Note Regarding Forward-Looking Statements" for information relating to these forward-looking statements. Risks Relating to our Business and Future Plans We have a history of net losses and expect to incur future losses, and there is substantial doubt about our ability to continue as a going concern. In the

View Full Filing

View this 10-K filing on SEC EDGAR

View on Read The Filing